Similar Articles
3361 Percutaneous local therapies for hepatocellular carcinoma impair gastric function
3362 Hepatocellular carcinoma in extremely elderly patients: An analysis of clinical characteristics, prognosis and patient survival
3363 Discrepancies between primary physician practice and treatment guidelines for Helicobacter pylori infection in Korea
3364 Risk factors for immediate post-operative fatal recurrence after curative resection of hepatocellular carcinoma
3365 Baseline characterization of patients aged 70 years and above with hepatocellular carcinoma
3366 Radiation therapy for portal venous invasion by hepatocellular carcinoma
3367 Impairment of IFN-α production capacity in patients with hepatitis C virus and the risk of the development of hepatocellular carcinoma
3368 Stool antigen tests in the diagnosis of Helicobacter pylori infection before and after eradication therapy
3369 Effects of L-carnitine in patients with hepatic encephalopathy
3370 Delayed development of hepatocellular carcinoma during long-term follow-up after eradication of hepatitis C virus by interferon therapy
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA